drugset / Trial / NCT01430910

A Study to Assess the Levels of Two Antibiotics in the Blood When Given Together and Separately

NCT01430910

Phase 1 Completed 43 enrolled Pfizer
RandomizedParallel-groupOpen-labelBasic science

Summary

This is a randomised study divided into 2 parts. Part A investigates the effect of prolonged dosing (ten days) with Avibactam and Ceftazidime when given together and how this will effect how much Avibactam and Ceftazidime enters the blood. Part B investigates how much Avibactam (NXL104) and Ceftazidime enter the blood when Avibactam and Ceftazidine are given separately or together intravenously.

Timeline

Start
2011-09
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ceftazidime Small molecule 2000 mg Intravenous
Comparator avibactam Small molecule 500 mg Intravenous

Indications

No indication recorded.